Eyegate Pharmaceuticals Company Profile (NASDAQ:EYEG)

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals logoEyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The Company is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EYEG
  • CUSIP:
Key Metrics:
  • Previous Close: $1.72
  • 50 Day Moving Average: $1.72
  • 200 Day Moving Average: $2.67
  • 52-Week Range: $1.31 - $5.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.83
  • P/E Growth: 0.00
  • Market Cap: $15.40M
  • Outstanding Shares: 8,951,000
  • Beta: 2.76
Additional Links:
Companies Related to Eyegate Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Eyegate Pharmaceuticals (NASDAQ:EYEG) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $9.00 (423.26% upside)

Analysts' Ratings History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
Show:
DateFirmActionRatingPrice TargetDetails
6/28/2016Maxim GroupReiterated RatingHoldView Rating Details
6/13/2016Rodman & RenshawReiterated RatingBuyView Rating Details
4/14/2016Chardan CapitalReiterated RatingBuyView Rating Details
4/7/2016Noble FinancialInitiated CoverageBuy -> Buy$10.00View Rating Details
2/1/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Eyegate Pharmaceuticals (NASDAQ:EYEG)
Current Year EPS Consensus Estimate: $-1.64 EPS
Next Year EPS Consensus Estimate: $-0.94 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.32)($0.32)($0.32)
Q2 20161($0.33)($0.33)($0.33)
Q3 20161($0.34)($0.34)($0.34)
Q4 20161($0.35)($0.35)($0.35)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Eyegate Pharmaceuticals (NASDAQ:EYEG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2016Stephen FromInsiderBuy15,000$1.49$22,350.00View SEC Filing  
6/15/2016Morton GoldbergDirectorSell15,000$3.16$47,400.00View SEC Filing  
6/10/2016Ventech Capital IiMajor ShareholderSell28,600$3.04$86,944.00View SEC Filing  
6/8/2016Ventech Capital IiMajor ShareholderSell29,400$3.25$95,550.00View SEC Filing  
6/7/2016Morton GoldbergDirectorSell10,939$3.31$36,208.09View SEC Filing  
2/19/2015(Innoven Partenaires S.A. IpsaMajor ShareholderBuy366,667$6.00$2,200,002.00View SEC Filing  
2/19/2015Paul G ChaneyDirectorBuy8,333$6.00$49,998.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Eyegate Pharmaceuticals (NASDAQ:EYEG)
DateHeadline
News IconCatching the Wonder of Investors: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 30 at 5:16 PM
News IconInterested Penny Stock Investors Keen on Shares of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 28 at 4:49 PM
News IconPenny Stock Investors are Growing Curious About Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 28 at 9:50 AM
investornewswire.com logoShares Of Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Expected To Hit $10 - Investor Newswire (NASDAQ:EYEG)
www.investornewswire.com - September 26 at 9:39 AM
News IconKeen Investors Find News on Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 23 at 4:42 PM
News IconUnder the Microscope, Zeroing in at Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 23 at 9:56 AM
News IconAnalysts Take the Wheel on Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:EYEG)
friscofastball.com - September 21 at 5:29 PM
News IconPenny Stock Investors Take an Interest in Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Duncan Research (NASDAQ:EYEG)
www.duncanindependent.com - September 21 at 5:29 PM
News IconEyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference - EconoTimes (NASDAQ:EYEG)
www.econotimes.com - September 21 at 5:29 PM
finance.yahoo.com logoEyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference (NASDAQ:EYEG)
finance.yahoo.com - September 21 at 9:10 AM
News IconLooking Ahead for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:EYEG)
friscofastball.com - September 20 at 8:47 AM
streetinsider.com logoEyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development (NASDAQ:EYEG)
www.streetinsider.com - September 15 at 5:19 PM
News IconValeant Pharmaceuticals Intl Inc (VRX) Is One Step Ahead in Ophthalmology Treatment - Smаrt Stоck Nеws (NASDAQ:EYEG)
www.smartstocknews.com - September 14 at 9:07 AM
News IconActive News in Reviews- Neuralstem (NASDAQ:CUR), MiMedx Group (NASDAQ:MDXG), Eyegate Pharmaceuticals ... - Seneca Globe (NASDAQ:EYEG)
www.senecaglobe.com - September 14 at 9:07 AM
News IconShares Gapping Up Pre-Trade: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Post News (NASDAQ:EYEG)
www.kentuckypostnews.com - September 14 at 9:07 AM
streetinsider.com logoEyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development - StreetInsider.com (NASDAQ:EYEG)
www.streetinsider.com - September 14 at 9:07 AM
streetinsider.com logoEyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License (NASDAQ:EYEG)
www.streetinsider.com - September 13 at 9:48 AM
globenewswire.com logoFunds to Advance Pre-clinical Development of CMHA-S Ocular Bandage Film (NASDAQ:EYEG)
globenewswire.com - September 13 at 9:48 AM
finance.yahoo.com logoEyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense (NASDAQ:EYEG)
finance.yahoo.com - September 13 at 9:48 AM
globenewswire.com logoEyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437 (NASDAQ:EYEG)
globenewswire.com - September 12 at 9:49 AM
News IconConsensus Estimates on Earnings & Stock Price in Focus for Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Shares - Frisco Fastball (NASDAQ:EYEG)
friscofastball.com - September 10 at 9:31 AM
finance.yahoo.com logoEyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference (NASDAQ:EYEG)
finance.yahoo.com - September 6 at 9:46 AM
News Icon2016 H2 diabetic macular edema pipeline market therapeutics assessment made available by top research firm (NASDAQ:EYEG)
www.whatech.com - September 2 at 9:49 AM
newsmaker.com.au logoDiabetic Macular Edema Pipeline Market 2016 Therapeutics Research (NASDAQ:EYEG)
www.newsmaker.com.au - August 31 at 4:51 PM
reuters.com logoBRIEF-Eyegate says selling stockholders may offer up to 871,000 shares of co's common stock (NASDAQ:EYEG)
in.reuters.com - August 31 at 4:51 PM
finance.yahoo.com logoEYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program (NASDAQ:EYEG)
finance.yahoo.com - August 29 at 4:51 PM
kcregister.com logoToday's Watch List: Eyegate Pharmaceuticals (NASDAQ:EYEG ... - KC Register (NASDAQ:EYEG)
www.kcregister.com - August 23 at 5:03 PM
finance.yahoo.com logoEYEGATE PHARMACEUTICALS INC Financials (NASDAQ:EYEG)
finance.yahoo.com - August 23 at 5:03 PM
investornewswire.com logoWill Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) Hit $10 Price Target? - Investor Newswire (NASDAQ:EYEG)
www.investornewswire.com - August 22 at 9:35 AM
reuters.com logoBRIEF-Eyegate Pharma Q2 net loss $3.823 million - Reuters (NASDAQ:EYEG)
www.reuters.com - August 11 at 6:12 AM
globenewswire.com logoEyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update - GlobeNewswire (press release) (NASDAQ:EYEG)
globenewswire.com - August 11 at 6:12 AM
biz.yahoo.com logoEYEGATE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:EYEG)
biz.yahoo.com - August 10 at 5:08 PM
finance.yahoo.com logoEyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:EYEG)
finance.yahoo.com - August 10 at 5:08 PM
News Icon2 Biotech Stocks News And Price Trends: Eyegate Pharmaceuticals (NASDAQ:EYEG), Halozyme Therapeutics ... - The Voice Registrar (NASDAQ:EYEG)
voiceregistrar.com - August 2 at 5:07 PM
streetupdates.com logoLast Analysts Rating Review: Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) , Eyegate Pharmaceuticals, Inc ... - Street Updates (NASDAQ:EYEG)
www.streetupdates.com - August 2 at 5:07 PM
reuters.com logoBRIEF-Eyegate Pharmaceuticals reports positive top-line data - Reuters (NASDAQ:EYEG)
www.reuters.com - August 2 at 5:07 PM
News IconBiotechnology Stocks in Limelight: Inotek Pharmaceuticals Corp (NASDAQ:ITEK), Eyegate Pharmaceuticals Inc ... - Post Registrar (NASDAQ:EYEG)
postregistrar.com - August 2 at 5:07 PM
fortune.com logoAnalysts: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) stock is worth $8.67 - Review Fortune (NASDAQ:EYEG)
reviewfortune.com - August 2 at 5:07 PM
schaeffersresearch.com logoBiotech Stocks Start Off August with a Bang (NASDAQ:EYEG)
www.schaeffersresearch.com - August 1 at 4:52 PM
finance.yahoo.com logoEyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of … (NASDAQ:EYEG)
finance.yahoo.com - August 1 at 9:45 AM
biz.yahoo.com logoEYEGATE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:EYEG)
biz.yahoo.com - August 1 at 8:32 AM
investornewswire.com logoIs $10 Price Target Attainable For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)? - Investor Newswire (NASDAQ:EYEG)
www.investornewswire.com - July 24 at 4:44 PM
News IconEyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Shorts Decreased by 4.26% After Short Covering - Press Telegraph (NASDAQ:EYEG)
presstelegraph.com - July 21 at 8:28 AM
investornewswire.com logoStrong Sell Calls For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) At 0 - Investor Newswire (NASDAQ:EYEG)
www.investornewswire.com - July 19 at 11:03 AM
ftsenews.co.uk logoNew Broker Ratings For Eyegate Pharmaceuticals, Inc. (EYEG) - FTSE News (NASDAQ:EYEG)
www.ftsenews.co.uk - July 16 at 8:21 AM
News IconEyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Sellers Covered 22.05% of Their Shorts - Consumer Eagle (NASDAQ:EYEG)
www.consumereagle.com - July 15 at 6:50 AM
News IconEyegate Pharmaceuticals Incorporated (NASDAQ:EYEG) Sellers Covered 22.05% of Their Shorts - Engelwood Daily (NASDAQ:EYEG)
www.engelwooddaily.com - July 10 at 4:41 PM
investornewswire.com logoIs $10 Within Reach For Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG)? - Investor Newswire (NASDAQ:EYEG)
www.investornewswire.com - July 10 at 4:41 PM
News IconStock Dipping Down in Session: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Telanagana Press (NASDAQ:EYEG)
telanaganapress.com - July 6 at 10:45 PM
News IconIncreased Volatility Watch for: Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) - Engelwood Daily (NASDAQ:EYEG)
www.engelwooddaily.com - July 6 at 10:45 PM

Social

Eyegate Pharmaceuticals (NASDAQ:EYEG) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff